Concourse Financial Group Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.86M | Buy |
|
|||||
|
2024
Q3 | $2.27M | Sell |
|
|||||
|
2024
Q2 | $2.3M | Buy |
|
|||||
|
2024
Q1 | $2.02M | Buy |
|
|||||
|
2023
Q4 | $1.67M | Buy |
|
|||||
|
2023
Q3 | $978K | Buy |
|
|||||
|
2023
Q2 | $897K | Buy |
|
|||||
|
2023
Q1 | $769K | Buy |
|
|||||
|
2022
Q4 | $525K | Buy |
|
|||||
|
2022
Q3 | $366K | Sell |
|
|||||
|
2022
Q2 | $448K | Sell |
|
|||||
|
2022
Q1 | $787K | Sell |
|
|||||
|
2021
Q4 | $1.39M | Buy |
|
|||||
|
2021
Q3 | $1.09M | Buy |
|
|||||
|
2021
Q2 | $888K | Sell |
|
|||||
|
2021
Q1 | $1.67M | Buy |
|
|||||
|
2020
Q4 | $1.19M | Buy |
|
|||||
|
2020
Q3 | $952K | Buy |
|
|||||
|
2020
Q2 | $798K | Buy |
|
|||||
|
2020
Q1 | $390K | Buy |
|
|||||
|
2019
Q4 | $238K | Buy |
|
|||||
|
2019
Q3 | $110K | Buy |
|
|||||
|
2019
Q2 | $118K | Buy |
|
|||||
|
2019
Q1 | $75K | Buy |
|
|||||
|
2018
Q4 | $21K | Buy |
|
|||||
|
2018
Q3 | $11K | Buy |
|